ArticleCureus2025
A Case of Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome With Pre-existing Sjögren's Syndrome and Autoimmune Hepatitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system (CNS). The coexistence of NMOSD and other autoimmune diseases is well recognized. Additionally, rare cases of NMOSD complicated by posterior reversible encephalopathy syndrome (PRES) have been reported. We present here a case of a young female who developed NMOSD in the clinical course of Sjögren's syndrome (SS) and autoimmune hepatitis (AIH), and who then rapidly developed PRES. A 28-year-old woman was admitted to our hospital with complaints of nausea and singultus, resulting in difficulty eating. She had been experiencing numbness from her neck to her upper arms prior to admission, and she also developed a decrease in visual acuity in her left eye after admission. Brain magnetic resonance imaging (MRI) revealed optic neuritis and a lesion in the area postrema. Based on these imaging findings and those symptoms described as acute myelitis, she was tentatively diagnosed with NMOSD, and treatment with steroids and plasmapheresis was initiated. The following day, however, she developed status epilepticus. Follow-up MRI showed edematous changes in the cortex and deep white matter of the frontal, parietal, and occipital lobes, as well as in the basal ganglia and cerebellum, accompanied by hemorrhage and meningeal enhancement. Her serum test turned out to be positive for anti-aquaporin-4 antibody later. Finally, she was diagnosed with PRES accompanied by NMOSD. It is of note to consider NMOSD when patients with autoimmune diseases present with neurological symptoms such as optic neuritis or acute myelitis. Based on previous reports and temporal changes in her antibody titers, SS may have been involved in the onset of NMOSD in this case. When NMOSD complicates SS, it can be challenging to distinguish CNS lesions caused by SS from those caused by NMOSD. Although previous reports on the coexistence of NMOSD and PRES are limited, several factors have been proposed to explain the mechanism underlying this pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.